| Mrs Hannah Giovannucci, PA | |
|
4220 Harding Pike, Nashville, TN 37205-2005 | |
| (615) 222-6977 | |
| Not Available |
| Full Name | Mrs Hannah Giovannucci |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 5 Years |
| Location | 4220 Harding Pike, Nashville, Tennessee |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972167500 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Saint Thomas West Hospital | Nashville, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Warner Physician Services Pc | 0345602801 | 46 |
| Saint Thomas Medical Partners | 1557269354 | 519 |
| Beaman Physician Services, Pc | 6406218130 | 48 |
| Crossroads Urgent Care Pllc | 8325117484 | 139 |
News Archive
Asuragen, Inc., a leader in the development of molecular diagnostics, announced today the appointment of Biomedical Diagnostics SA, a leading medical diagnostic company in Europe, as its exclusive distributor of Signature® Oncology Products in France. Asuragen's Signature Oncology Portfolio comprises multiplex assays for the detection of mutations in solid and hematologic malignancies.
URAC announced today that a distinguished panel of judges has selected 30 finalists for its Best Practices in Health Care Consumer Empowerment and Protection Awards. The competition drew entries from across the nation. The finalists will be honored during URAC's 11th Annual Quality Summit, October 5-7, 2010 in Chicago, IL. The awards honor programs in two areas: Consumer Decision-Making and Consumer Health Improvement.
On the fourth floor of Wichita State University's McKinley Hall, biochemistry professor Kandatege Wimalasena and his group of doctoral and undergraduate students are hard at work researching Parkinson's disease (PD) - the second-most common neurodegenerative disease, affecting 1 to 2 percent of people older than 60.
Cytogen Corporation has announced that it has been issued United States patent number 7,135,457 covering its oral drug delivery agents - random peptide compositions that bind to gastro-intestinal tract (GIT) transport receptors.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Hannah Giovannucci, PA 1166 Carney Winters Rd, Ashland City, TN 37015-4629 Ph: (860) 878-5307 | Mrs Hannah Giovannucci, PA 4220 Harding Pike, Nashville, TN 37205-2005 Ph: (615) 222-6977 |
News Archive
Asuragen, Inc., a leader in the development of molecular diagnostics, announced today the appointment of Biomedical Diagnostics SA, a leading medical diagnostic company in Europe, as its exclusive distributor of Signature® Oncology Products in France. Asuragen's Signature Oncology Portfolio comprises multiplex assays for the detection of mutations in solid and hematologic malignancies.
URAC announced today that a distinguished panel of judges has selected 30 finalists for its Best Practices in Health Care Consumer Empowerment and Protection Awards. The competition drew entries from across the nation. The finalists will be honored during URAC's 11th Annual Quality Summit, October 5-7, 2010 in Chicago, IL. The awards honor programs in two areas: Consumer Decision-Making and Consumer Health Improvement.
On the fourth floor of Wichita State University's McKinley Hall, biochemistry professor Kandatege Wimalasena and his group of doctoral and undergraduate students are hard at work researching Parkinson's disease (PD) - the second-most common neurodegenerative disease, affecting 1 to 2 percent of people older than 60.
Cytogen Corporation has announced that it has been issued United States patent number 7,135,457 covering its oral drug delivery agents - random peptide compositions that bind to gastro-intestinal tract (GIT) transport receptors.
› Verified 5 days ago